The company is built around Lacritin, a protein that company co-founder and UVA researcher Gordon Laurie discovered in 2001. He found the protein lacking in patients with dry eye, so he isolated the active ingredient into an eye drop medication called Lacripep. The company spun out of UVA in 2013.